A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment

NCT02902679 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis
Factor XI
Renal Impairment
ESRD (End-Stage Renal Disease)

Interventions

DRUG: BMS-986177

Sponsor

Bristol-Myers Squibb